More than 240 pharmaceutical companies have disclosed performance forecasts, with dazzling net profits concentrated in the fields of vaccines and testing
Time of Update: 2022-05-02
. In addition to Zhifei Bio and CanSino, the net profit of vaccine companies such as Olin Bio and Kangtai Bio is also expected to increase significantly year-on-year in 2021.
PPG expands powder coatings business with acquisition
Time of Update: 2022-03-05
Following the acquisition, PPG will be able to expand its powder coatings product range in the Europe, Middle East and Africa (EMEA) region to include metal bonding powders, one of the fastest growing markets for powder coatings, typically used in automotive, appliance and General specialty finishes for industrial applications .
PetroChina and Sinopec sell all oil and gas pipeline assets
Time of Update: 2021-09-04
Speeding up the reform process of pipe network separation Sinochem Xinnet News On July 23, PetroChina and Sinopec issued an announcement at the same time, announcing that they intend to sell their oil and gas pipeline assets to the National Pipeline Network Group .
New crown pneumonia epidemic: U.S. pork processing rebounds to 95% of 2019 levels
Time of Update: 2021-04-29
swH China Feed Industry Information Network-Based on feed, serving animal husbandry Although Tyson Foods closed a pork factory in Iowa for a few days due to an employee contracting the new crown pneumonia epidemic last week, it did not resume limited production until June 3.
2016 National Titanium White Powder Enterprise Third Quarter Analysis
Time of Update: 2021-01-06
Relatively regressing companies such as Huntsman reported sales of $2,363 million in the third quarter of 2016, down 10 percent from $2,638 million in the same period in 2015, and adjusted earnings before interest, tax, depreciation and amortization (EBITDA) of $272 million in the third quarter.
Two clinical failures in six months Pfizer's $5 billion heavy-weight drug challenge
Time of Update: 2020-10-23
01 Clinical failure October 10, Pfizer announced that its target cancer drug Iberance (Chinese commodity name: Aiboxin, generic name: palbociclib, erbasilli) for treatment after the completion of the new auxiliary chemotherapy is still soaked Phase 3 PENELOPE-B trials in patients with early stage PENELOPE-B of the hormone-positive/human epithet growth factor -2 negative (HR-/HER2-) early breast cancer (eBC) did not reach the primary endpoint of improving the survival of non-invasive diseases (iDFS).
New oral antifungal drug introduced by Hengrui for $110 million approved for clinical trial in China
Time of Update: 2020-05-28
Author: On May 20, , Hengrui Class 1 new drug SHR8008 capsules were approved for clinical treatment in China for the treatment of recurrent vulvar vaginal fissy (RVVC) The drug is a new oral antifunga
This pharmaceutical company is the king of oversubscription of 2019 Hong Kong stock new share company. What's the reason
Time of Update: 2019-10-29
[industry trends of pharmaceutical network] on October 28, AXA pharmaceuticals was officially listed on the Hong Kong stock exchange, with a total of 12.18809 million shares issued, 50% of which were
2019 pharmaceutical industry focuses on value investment
Time of Update: 2019-03-07
"We should not expect 2019 to be a new drug harvest year like 2018 ——At last year's JPM, Jamie Munro's biopharmaceutical trade trend analysis showed that as targeted therapy continues to cause changes
Review and approval of drugs & report on the market situation, upgrade the drug supervision action, attack the tax heavily, and the elimination competition of drug companies has become white hot
Time of Update: 2018-06-11
Drug review, approval & report of drug listing in May the data of drug acceptance, approval and consistency evaluation application are published! In May, the total acceptance amount of the drug examin
Why is the health of space medicine so hot
Time of Update: 2017-11-23
[market analysis of China Pharmaceutical network] Why is medical health so hot?
GlaxoSmithKline's new strategy -- Viiv healthcare will be launched
Time of Update: 2015-02-09
Source: Biovalley, February 8, 2015, GSK, a pharmaceutical giant, released a series of performance growth plans after announcing its poor performance in the previous year, in order to make a good star
Ensemble pharmaceutical and Novartis reach a global strategic cooperation
Time of Update: 2013-08-07
Source: Biovalley 2013-8-7 ensemble pharmaceutical announced today that it has reached a two-way global strategic cooperation with Novartis to develop an oral IL-17 antagonist project and develop smal